New Study Strengthens Link between Ulcerative Colitis and Accutane
Since first entering the market, there have been many health risk warnings regarding the acne drug Accutane. Specifically, Accutane has been associated with an increased risk of developing a digestive disorder known as inflammatory bowel disease (IBD). IBD refers to a group of digestive disorders that includes ulcerative colitis and Crohn’s Disease. A new study in the American Journal of Gastroenterology found that patients taking Accutane are four times more likely than non-users to develop ulcerative colitis.
Although the risk of developing ulcerative colitis is rather small, the findings support a cause-and-effect relationship between Accutane and IBD. Accutane was taken off the market in 2009 by its manufacturer Roche Pharmaceuticals. In early 2009, Roche paid $25 million in damages to a patient who took Accutane and developed IBD.
Contact our Experienced Attorneys
If you or a loved one has been diagnosed with an inflammatory bowel disease such as ulcerative colitis or Crohn's Disease after taking Accutane, contact our law firm today. We will provide you with a free no-obligation consultation and explain your rights.